SCHEMBL8817880

SCHEMBL8817880

O=C(O)C1=CCCN(CCC=C(c2ccccc2)c2ccoc2)C1

nearest known ligand 0.81

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 3/20 0.81
ALDH1A1 P00352 4/20 0.49
LMNA P02545 4/20 0.49
KDM4E B2RXH2 2/20 0.49
BLM P54132 2/20 0.49
PMP22 Q01453 2/20 0.49
KMT2A Q03164 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
TP53 P04637 1/20 0.49
ALOX12 P18054 1/20 0.49
MAPK1 P28482 1/20 0.49
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SIGMAR1 Q99720 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7356644 0.96 SLC6A1 (0.72) SLC6A1ALDH1A1LMNAKDM4EBLM
SCHEMBL5162505 0.90 SLC6A1 (1.00) SLC6A1ALDH1A1LMNAKDM4EBLM
Hydrochloric Acid SCHEMBL10964415 0.89 SLC6A1 (0.97) SLC6A1ALDH1A1LMNAKDM4EBLM
SCHEMBL7358137 0.87 SLC6A1 (0.61) SLC6A1ALDH1A1LMNAKDM4EBLM
SCHEMBL7399137 0.86 SLC6A1 (0.60) SLC6A1ALDH1A1LMNAKDM4EBLM
SCHEMBL9526360 0.84 SLC6A1 (0.86) SLC6A1ALDH1A1LMNAKDM4EBLM
SCHEMBL9526552 0.83 SLC6A1 (0.77) SLC6A1ALDH1A1LMNAKDM4EBLM
SCHEMBL9525891 0.82 SLC6A1 (0.83) SLC6A1ALDH1A1LMNAKDM4EBLM
SCHEMBL9525459 0.81 SLC6A1 (0.81) SLC6A1ALDH1A1LMNAKDM4EBLM
SCHEMBL8820395 0.80 SLC6A1 (0.79) SLC6A1ALDH1A1LMNAKDM4EBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997049403-A1 USE OF NIPECOTIC ACID OR GUVACINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF POSTISCHEMIC NEURODEGENERATIVE DISORDERS UNIVERSITY COLLEGE DUBLIN (US) 1997-12-31 WO disclosed
EP-0231996-B1 NOVEL AMINO ACID DERIVATIVES NOVO NORDISK A/S (DK) 1993-10-06 EP disclosed
EP-0231996-A2 Novel amino acid derivatives NOVO NORDISK A/S (DK) 1987-08-12 EP disclosed